UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Historical Holders from Q3 2021 to Q2 2025

Symbol
UNCY on Nasdaq
CUSIP
90466Y103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
18.6M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-29
Average Value change %
0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 9.99% $32.3M 61M Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $7.04M $936K 13.3M +15.3% RA Capital Management, L.P. Mar 31, 2025
GREAT POINT PARTNERS LLC 9.99% $6.08M 11.5M Great Point Partners, LLC Dec 31, 2024
Walleye Capital LLC 4.82% $2.65M 5M Walleye Capital LLC Dec 31, 2024
Nantahala Capital Partners Limited Partnership 2.76% -62.5% $1.59M -$2.59M 3.01M -61.9% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Dec 19, 2024
Nantahala Capital Management, LLC 9.99% 0% $1.02M $342K 1.86M +50.3% Nantahala Capital Management, LLC Sep 30, 2025

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$34.5M 0
2025 Q1 59.9M $34.5M -$1.35M $0.57 29
2024 Q4 61.7M $49M +$12.1M $0.79 31
2024 Q3 46.8M $19.1M +$10.6M $0.41 28
2024 Q2 19M $9.52M -$954K $0.50 23
2024 Q1 14.4M $19.9M +$6.69M $1.38 21
2023 Q4 13M $11.3M -$1.01M $0.87 16
2023 Q3 14.2M $12.2M +$11.2M $0.86 16
2023 Q2 1.07M $1.38M -$1.38M $1.28 15
2023 Q1 1.69M $3.54M +$1.99M $2.10 13
2022 Q4 795K $428K -$99.2K $0.54 9
2022 Q3 967K $570K -$124K $0.59 10
2022 Q2 1.19M $991K +$38.2K $0.83 13
2022 Q1 1.13M $1.44M +$30.5K $1.28 10
2021 Q4 1.12M $2.3M -$90.2K $2.06 9
2021 Q3 1.07M $3.02M +$3.01M $2.83 9